729
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes, and low platelets syndrome

, , , &
Pages 1352-1362 | Received 04 Nov 2019, Accepted 08 Apr 2020, Published online: 19 Apr 2020

References

  • Sibai BM. Imitators of severe preeclampsia. Obstet Gyncol. 2007;109:956–966.
  • Vigil-De Gracia P. Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders. Int J Gynecol Obstetr. 2001;73(3):215–220.
  • Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209(5):456.e1–7.
  • Nelson DB, Yost NP, Cunningham FG. Hemostatic dysfunction with acute fatty liver of pregnancy. Obstet Gynecol. 2014;124:40–46.
  • Martin JN, Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991;164(6):1500–1513.
  • Tarnier. Note sur l’etat graisseux du foie dans la fievre peurperale. C R Soc Biol. 1857;3:209–214.
  • Lomer O. Ueber die Bedeutung des Icterus gravidarum, etc. Zeitschr f Geb u Gyn. 1886;xiii:169–185.
  • Williams JW. Obstetrics: a textbook for students and practitioners. London: D Appelton and Company; 1903.
  • Sheehan HL. The pathology of acute yellow atrophy and delayed chloroform poisoning. BJOG. 1940;47(1):49–62.
  • Burroughs AK, Seong NH, Dojcinov DM, et al. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med. 1982;51(204):481–497.
  • Ch’ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwester Wales. Gut. 2002;51:876–880.
  • Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57(7):951–956.
  • Sheehan HL, Lynch JB. Pathology of toxaemia of pregnancy. Baltimore: Williams & Wilkins; 1973.
  • Chesley L. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts; 1978.
  • Pritchard JA, Weisman R, Jr, Ratnoff OD, et al. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954;250(3):89–98.
  • Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976;124(8):855–864.
  • Arias F, Mancilla-Jimenez R. Hepatic fibrinogen deposits in preeclampsia. Immunofluorescent evidence. N Engl J Med. 1976;295(11):578–582.
  • Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–167.
  • Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000–1006.
  • Martin JN, Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180(6):1373–1384.
  • Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999;181(2):389–395.
  • Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut. 1994;35(1):101–106.
  • Monga M, Katz AR. Acute fatty liver in the second trimester. Obstet Gynecol. 1999;93(5 Pt 2):811–813.
  • Bacq Y. Liver disease unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenterol. 2011;35(3):182–193.
  • Davidson KM, Simpson LL, Knox TA, et al. Acute fatty liver of pregnancy in triplet gestation. Obstet Gynecol. 1998;91(5 Pt 2):806–808.
  • Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: an experience in diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994;171(5):1342–1347.
  • Reubinoff BE, Schenker JG. HELLP Syndrome – a syndrome of hemolysis, elevated liver enzymes and low platelet count – complicated preeclampsia-eclampsia. Int J Gynecol Obstet. 1991;36(2):95–102.
  • Malmström O, Morken N-H. HELLP syndrome, risk factors in first and second pregnancy: a population-based cohort study. Acta Obstet Gynecol Scand. 2018;97(6):709–716.
  • Martin JN, Brewer JM, Wallace K, et al. HELLP syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med. 2013;26(12):1201–1206.
  • Sibai BM, Taslimi MM, el-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155(3):501–509.
  • Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340(22):1723–1731.
  • Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol. 1998;178(3):603–608.
  • Santos L, Patterson A, Moreea SM, et al. Acute liver failure in pregnancy associated with maternal MCAD deficiency. J Inherit Metab Dis. 2007;30(1):103–103.,
  • Sims HF, Brackett JC, Powell CK, et al. The molecular basis of pediatric long chain 3-hydroxyacyl-Co-A dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA. 1995;92(3):841–845.
  • Ylitalo K, Vanttinen T, Halmesmaki E, et al. Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency. Am J Obstet Gynecol. 2005;192(6):2060–2062.
  • Yang Z, Zhao Y, Bennett MJ, et al. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol. 2002;187(3):715–720.
  • Yang Z, Yamada J, Zhao Y, et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA. 2002;288(17):2163–2166.
  • Egerman RS, Sibai BM. Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol. 1999;42(3):551–562.
  • Phipps EA, Thadhani R, Benzing T, et al. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275–289.
  • Haggerty CL, Seifert ME, Tang G, et al. Second trimester anti-angiogenic proteins and preeclampsia. Pregnancy Hypertens. 2012;2(2):158–163.,
  • Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol. 1999;19(2):138–143.
  • Schrocksnadel J, Sitte B, Steckel-Berger G, et al. Hemolysis in hypertensive disorders of pregnancy. Gynecol Obstet Invest. 1992;34(4):211–216.
  • Nelson DB, Khan A, Bailey A, et al. Liver injury in hemolysis, elevated liver enzymes, and low platelets syndrome measured by diffusion-weight magnetic resonance imaging. Amer J Perinatol. 2018;35(08):741–747.
  • Ditisheim A, Sibai BM. Diagnosis and management of HELLP syndrome complicated by liver hematoma. Clin Obstet Gynecol. 2017;60(1):190–197.
  • American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131.
  • Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31(4):807–833.
  • Kenny L, McCrae K, Cunningham FG. Platelets, coagulation, and the liver. In: Taylor R, Roberts JM, editors. Chesley’s hypertension in pregnancy. Cambridge, MA: Academic Press; 2015. p. 379–396.
  • Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010;(9):CD008148.
  • Moldenhauer JS, O'Brien JM, Barton JR, et al. Acute fatty liver of pregnancy associated with pancreatitis: a life-threatening complication. Am J Obstet Gynecol. 2004;190(2):502–505.
  • Martin JN, Briery NM, Rose CH, et al. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher. 2008;47:113–115.
  • de Naeyer S, Ysebaert D, van Utterbeeck M, et al. Acute fatty liver of pregnancy and molecular absorbent recirculating system (MARS)- therapy: a case report. J Matern Fetal Neonatal Med. 2008;21(8):587–589.
  • Habli M, Eftekhari N, Wiebracht E, et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol. 2009;201:385e1–385e5.
  • Sibai BM, Ramadan MK, Chri RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172(1):125–129.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.